Pharmosa Biopharm Inc. (TPEX:6875)
Taiwan
· Delayed Price · Currency is TWD 49.60
+0.25 (0.51%)
May 21, 2025, 1:30 PM CST
Pharmosa Biopharm Market Cap
Pharmosa Biopharm has a market cap or net worth of 6.40 billion as of May 21, 2025. Its market cap has decreased by -19.78% in one year.
Market Cap
6.40B
Enterprise Value
5.08B
Revenue
167.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
49.60
Market Cap Chart
Since February 22, 2022, Pharmosa Biopharm's market cap has increased from 4.86B to 6.40B, an increase of 31.79%. That is a compound annual growth rate of 8.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2025 | 6.40B | -6.24% |
| Dec 31, 2024 | 6.83B | -33.79% |
| Dec 29, 2023 | 10.31B | 46.19% |
| Dec 30, 2022 | 7.06B | 45.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 166.85B |
| Caliway Biopharmaceuticals | 133.74B |
| Bora Pharmaceuticals Co., LTD. | 78.34B |
| Lotus Pharmaceutical | 60.43B |
| Polaris Group | 33.12B |
| Oneness Biotech | 29.27B |
| Center Laboratories | 27.70B |
| Pegavision | 27.57B |